Fertilis

We're excited to welcome to the Fertilis team Tim Prins as our Product Manager and Mel Carstensen as our Regulatory and QA specialist! Tim brings a wealth of experience in product development, and we're thrilled to see him drive our innovations forward with our mission to improve and enhance IVF outcomes. Mel's expertise in quality assurance and regulatory affairs ensures that our products meet the highest standards of safety and precision. At Fertilis, we believe that passion drives success, but having a little fun along the way is just as important. (And if you look closely, you might find a little easter egg that reflects just how much we enjoy making every day interesting!) With their talents on board, the future of our IVF technology just got a lot more exciting.

Join Our Team at Fertilis! We're excited to announce that Fertilis is looking for a Quality Manager. If you're driven by excellence and eager to contribute to advancing IVF technology, we are keen to hear from you.

Celebrating World Embryologist Day! Today, we honour the incredible work of embryologists worldwide who play a crucial role in helping families realise their dreams. At Fertilis, we're especially proud of our dedicated embryology team, who work tirelessly to develop our micro medical devices and advocate on behalf of our partners. Their passion, expertise, and relentless pursuit of excellence are not just advancing technology but are making a real difference. Here's to embryologists, who are the unsung heroes behind every successful IVF procedure. Megan Inge | Shauna Heinrich | #WorldEmbryologistDay #IVFExcellence #InnovationInIVF #FertilisFamily

Thanks Femtech Insider for a great piece on our microICSI prototype. We will be moving forward now to complete the design and seek regulatory approval before we can bring any product to market. #ivf #icsi #fertilitytreatment #fertility

New paper alert:  Severe male infertility can only be treated using intracytoplasmic sperm injection (ICSI), but it is a technically demanding procedure. Our latest publication in the Journal of Assisted Reproduction and Genetics (JARG) demonstrates that a 3D printed microstructure called microICSI, designed to hold a pig oocyte securely in place when performing ICSI (microICSI), simplifies the ICSI procedure and reduces the stress on the oocyte during injection as determined by subsequent embryo development.    Read the paper below: Our research shows that microICSI was quicker to perform than conventional ICSI, with similar time-saving results replicated in a human oocyte pilot study.  It was also easier to perform microICSI, as the holding pipette is no longer required and the number of microscope focussing, and injection controller movements is halved.   We also observed a 56% increase in the number of pig blastocysts produced when using microICSI compared to conventional ICSI.    Usability evaluations of microICSI with clinical embryologists are currently underway.    #icsi #technology #Fertilis #infertility #innovation #medtech #automation #embryology 

Check out Megan Inge speak on behalf of Fertilis at the International Human Embryology Research Academy on the 18th of November on 'Improvements to Intracytoplasmic Sperm Injection Facilitated by a Micron-3D Printed Device'. #icsi #ivf #technology #embryology #Fertilis #innovation #medtech #infertility #automation #iHERA

Our CEO Marty Gauvin sat down with Thomas Hickey of the Med Tech Gurus podcast to chat through best practices for any start-up CEO, concepts on finding the right investor for your start-up and what Fertilis is up to in developing and commercialising #IVF devices to improve outcomes. Check out the link below for more. #infertility #technology #embryology #Fertilis #innovation #medtech #automation